Skip to main content

Celebrex is a Risky Choice for Patients with Heart Problems

By April 2, 2008July 17th, 2019Drug Safety

Celebrex is risky choice for patients with heart problems,. According to a recently released study, the pain reliever increases the odds that people with heart problems will suffer a heart attack or stroke.
The study of the Pfizer-made drug was supported by the National Cancer Institute. It analyzed six studies conducted of 7,950 patients. Citing the Wall Street Journal, Reuters reported that researchers found that Celebrex “was associated with an increased risk of cardiovascular death, heart attack, stroke, heart failure or thromboembolic event, or events related to blood clots, compared to patients not taking the drug.”
Moreover, patients who received 400 milligrams of Celebrex twice a day had a three times higher risk of heart attacks and strokes compared with patients who had not taken the drug. Patients who were only given the 400 milligram dosage once a day had a 10 percent higher risk of a cardiovascular event.
Celebrex belongs to a class of drugs known as COX-2 inhibitors. Vioxx, also a COX-2 inhibitor, was removed from the market in 2004 after it was linked to heart attacks and sudden cardiac deaths. Another COX-2 inhibitor, Bextra, was also pulled from the market.
The lawyers of Carey, Danis & Lowe are experienced in helping people injured by a dangerous prescription drug. We will seek compensation for past and future medical expenses, past and future wages, pain and suffering, disability and other damages. We also represent family members in wrongful death cases.
We offer a free initial consultation for victims of dangerous medications. If you cannot make it to our office, we will come to you at the hospital or your home.
Contact the lawyers at Carey, Danis & Lowe today by calling 877-678-3400.